Park National Corp OH Decreases Stock Position in The Clorox Company $CLX

Park National Corp OH lowered its stake in The Clorox Company (NYSE:CLX) by 4.1% during the 2nd quarter, Holdings Channel reports. The firm owned 3,165 shares of the company’s stock after selling 137 shares during the quarter. Park National Corp OH’s holdings in Clorox were worth $380,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Raymond James Financial Inc. lifted its stake in Clorox by 15.6% in the 1st quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after purchasing an additional 36,352 shares in the last quarter. OneDigital Investment Advisors LLC purchased a new stake in shares of Clorox during the 1st quarter valued at about $247,000. Brown Miller Wealth Management LLC purchased a new stake in shares of Clorox during the 1st quarter valued at about $399,000. Roman Butler Fullerton & Co. purchased a new stake in shares of Clorox during the 1st quarter valued at about $400,000. Finally, Wedge Capital Management L L P NC raised its position in shares of Clorox by 33.5% during the 1st quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company’s stock valued at $4,198,000 after buying an additional 7,159 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE:CLX opened at $123.75 on Friday. The company has a market capitalization of $15.14 billion, a price-to-earnings ratio of 18.98, a PEG ratio of 1.00 and a beta of 0.52. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The firm’s 50-day moving average is $124.27 and its 200 day moving average is $132.30. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th were paid a $1.24 dividend. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. This is an increase from Clorox’s previous quarterly dividend of $1.22. Clorox’s payout ratio is currently 76.07%.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on CLX shares. UBS Group decreased their target price on shares of Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a research report on Thursday, July 17th. Morgan Stanley decreased their target price on shares of Clorox from $150.00 to $137.00 and set an “equal weight” rating on the stock in a research report on Friday, August 1st. Barclays decreased their target price on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 15th. Wells Fargo & Company decreased their target price on shares of Clorox from $138.00 to $130.00 and set an “equal weight” rating on the stock in a research report on Friday, September 5th. Finally, JPMorgan Chase & Co. upped their target price on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. One investment analyst has rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $142.18.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.57% of the stock is owned by corporate insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.